期刊文献+

幽门螺杆菌临床分离株耐药特性分析及嗜酸乳杆菌对耐药幽门螺杆菌的抑制作用 被引量:4

The analysis of drug resistance characteristics in clinical isolated ltelicobacter pylori strains from different gastropathy patients and the inhibitory effect of Lactobacillus acidophilus on drug-resistant Helicobacterpylori
原文传递
导出
摘要 目的对84株临床分离幽门螺杆菌(Helicobacter pylori,Hp)菌株进行耐药特性分析,并同时观察抗Hp嗜酸乳杆菌(Lactobacillus acidophilus,La)4和La6对不同抗生素耐药Hp的抑制效应。方法从84例不同胃病(慢性胃炎25例,胃溃疡24例,十二指肠溃疡19例,胃癌16例)患者胃黏膜中分离培养Hp菌株,采用E—test法测定甲硝唑、克拉霉素和阿莫西林3种常用抗生素对临床Hp菌株的最小抑菌浓度(MIC值),了解临床Hp菌株对3种抗生素的耐药状况。以标准L&作对照,将抗HpLa4和La6上清液加入含不同Hp菌株培养板的孔中,固体培养72h,记录抑菌环;抗HpLa菌液加入含不同Hp菌株的培养液中,液体培养,于不同时间点(4、8、12、24和48h)分别取培养液,计算菌落形成单位和测定尿素酶活性。结果84株临床分离Hp菌株中对甲硝唑、克拉霉素和阿莫西林的耐药率分别为67.9%、17.9%和1.2%。其中11株为混合耐药,包括10株甲硝唑和克拉霉素混合耐药和1株甲硝唑和阿莫西林混合耐药。在固体培养条件下抗HpLa4和La6上清液对抗生素耐药和非耐药Hp菌株均产生明显的抑菌效应。液体培养条件下抗HpLa4和La6菌液能抑制抗生素耐药和非耐药Hp菌株的增殖,其拮抗Hp的作用明显强于标准La菌株(p〈0.01)。抗HpLa4和La6在混合培养4h就能抑制抗生素耐药Hp菌株尿素酶活性,随着培养时间的延长Hp尿素酶活性逐渐降低,其抑制作用明显强于标准La组(P〈0.05)。结论84株临床分离Hp菌株中甲硝唑耐药株为常见,其次为克拉霉素耐药和甲硝唑克拉霉素混合耐药株。抗HpLa4和La6在体外对抗生素耐药和非耐药Hp菌株均具有明显的抑制作用。 Objective To analyze the drug resistant characteristics of 84 clinical isolated Helicobacter pylori (Hp) strains, and to observe the inhibitory effects of anti Hp Lactobacillus acidophilus (La)4 and La6 on different antibiotic resistant Hp strains. Methods Hp strains were isolated and cultured from gastric mucosa of 84 different gastropathy patients (20 patients with chronic gastritis, 24 with gastric ulcer, 19 with duodenal ulcer and 16 with gastric cancer). The minimum inhibitory concentration (MIC) of rnetronidazole, clarithromycin and amoxicillin were tested by E-test in order to determine the resistance of these three antibiotics in clinical isolated Hp strains. With standard La as control, the supernatant of anti-Hp La4 and La6 was added into Hp strains culture wells. Hp strains were cultured in solid media for 72 hours, and then inhibition ring were recorded. Anti-Hp Lactobaeillus aeidophilus liquid was also added to culture medium of different Hp strains, which were in liquid culture, culture medium were taken at different time points (4,8,12,24,48 hrs) to calculate bacteria colony number and test urease activity. Results In 84 clinical isolated Hp strains, the resistant rates of metronidazole, clarithromycin and amoxicillin resistance rates were 67.9%, 17. 9% and 1. 2% respectively. Of those 11 strains were mixed drug resistance, which included 10 strains of metronidazole and clarithromycin mixed drug resistance, and one of metronidazole and amoxicillin mixed drug resistance. In solid culture conditions, supernatant of anti- Hp Lactobacillus acidophilus La4 and La6 had obvious inhibitory effect on antibiotic resistant and non- resistant Hp strains. In liquid culture conditions, anti-Hp Lactobacilln acidophilus La4 and La6 bacterium liquid could inhibit the proliferation of antibiotic-resistant and non-resistant Hp strains, the antagonistic role was significantly stronger than the standard Lactobacillus acidophilus strains (P〈 0.05). The urease activity of antibiotic-resistant Hp strains was inhibited since mixed cultured with anti-Hp Lactobacillu acidophilus La4 and La6 for 4 hours, the urease activity gradually decreased as culture time extended, and the inhibitory role was significantly stronger than the standard Lactobacillus acidophilus strains (P〈0. 05). Conclusions In 84 Hp strains, most were metronidazole resistant strains, followed by clarithromycin resistant strains, metronidazole and clarithromycin mixed resistance strains. In vitro, anti Hp Lactobacillu acidophilus La4 and La6 had obvious inhibitory effects on antibiotic-resistant and non-resistant Hp strains.
出处 《中华消化杂志》 CAS CSCD 北大核心 2011年第7期465-469,共5页 Chinese Journal of Digestion
基金 基金项目:吉林省科技发展计划资助项目(20050202-1)
关键词 螺杆菌 幽门 抗药性 微生物 嗜酸乳杆菌 甲硝唑 克拉霉素 阿莫西林 胃疾病 Helicobacter pylori Drug resistance, microbial Lactobacillus acidophilus Metronidazole Clarithromyein Amoxicillin~ Stomach disease
作者简介 通信作者:王江滨,Email:zrlwangjb@medmail.com.cn
  • 相关文献

参考文献5

二级参考文献27

  • 1范学工,幽门螺杆菌感染与临床,1997年,1页
  • 2徐迪城,厌氧菌数值鉴定指南,1992年,22页
  • 3Pajares JM,Gisbert JP.Helicobacter pylori:its discovery and relevance for medicine[J].Rev Esp Enferm Dig,2006;98(10):770-85.
  • 4Timmerman HM.Together strong:probiotics to promote health in people and animals[J].Tijdschr Diergeneeskd,2006 ;131 (19):697-700.
  • 5Hamilton-Miller.The role of probiotics in the treatment and prevention of Helionbacter pylori infection[J].J M Int J Antimicrob Agents,2003 ;22(4):360-6.
  • 6Lee JH,Park EK,Uhm CS,et al.Inhibition of helicobacter pylori adhesion to human gastric adenocarcinoma epithelial cells by acidic polysaccharides from artemisia capillaris and panax ginseng[J].Planta Med,2004;70(7):615-9.
  • 7Wang KY,Li SN,Liu CS,et al.Effects of ingesting Lactobacillusand bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori[J].Am J Clin Nutr,2004 ;10:737-41.
  • 8Xanthopoulo V,Litopoulou Tzanetaki E,Tzanetakis,et al.Characterization of Lactobacillus isolates from infant faeces as dietary adjuncts[J].Food Microbiology,2000; 17:205 -15.
  • 9Buchanan RE,Gibbens NE.伯杰细菌鉴定手册[M].第8版.北京:科学出版社,1984:797-822.
  • 10Zarate G,Perez-Chaia A,Gonzale S,et al.Viability and B-galactosidase activity of dairy propionibacteria subjected to digestion by artificial gastric and intestinal fluids[J].Food Protection,2000 ;63:1214-21.

共引文献24

同被引文献36

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部